Wealthspire Advisors LLC Decreases Stock Position in Colgate-Palmolive (NYSE:CL)

Wealthspire Advisors LLC trimmed its holdings in shares of Colgate-Palmolive (NYSE:CL) by 2.6% during the 4th quarter, HoldingsChannel.com reports. The firm owned 12,899 shares of the company’s stock after selling 343 shares during the quarter. Wealthspire Advisors LLC’s holdings in Colgate-Palmolive were worth $1,173,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Chicago Partners Investment Group LLC boosted its position in shares of Colgate-Palmolive by 16.2% during the fourth quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock valued at $591,000 after buying an additional 943 shares during the last quarter. Peak Financial Advisors LLC purchased a new stake in shares of Colgate-Palmolive during the 4th quarter valued at about $1,315,000. Gordian Advisors LLC bought a new stake in shares of Colgate-Palmolive in the third quarter worth approximately $602,000. Carrera Capital Advisors grew its stake in shares of Colgate-Palmolive by 23.1% in the third quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock worth $4,066,000 after acquiring an additional 7,353 shares during the period. Finally, Fiduciary Alliance LLC purchased a new position in shares of Colgate-Palmolive during the fourth quarter valued at approximately $4,066,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

NYSE:CL opened at $90.10 on Tuesday. The business’s 50-day simple moving average is $88.88 and its two-hundred day simple moving average is $95.73. Colgate-Palmolive has a 52 week low of $85.32 and a 52 week high of $109.30. The stock has a market cap of $73.12 billion, a PE ratio of 25.60, a P/E/G ratio of 4.20 and a beta of 0.44. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the prior year, the firm posted $0.87 EPS. As a group, analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.22%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.

Analysts Set New Price Targets

CL has been the subject of a number of research analyst reports. Piper Sandler cut their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday, January 6th. Stifel Nicolaus reduced their price objective on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research report on Monday, February 3rd. TD Cowen lowered their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, January 8th. UBS Group cut their price target on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research note on Monday, February 3rd. Finally, StockNews.com cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Hold” and a consensus price target of $101.16.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.